Addition of Dapagliflozin to Part 7

Published: 28/08/25

From the 1st of September 2025, Dapagliflozin 5mg and 10mg tablets (Forxiga Tablets) shall be added to Part 7 of the Scottish Drug Tariff.

---

This comes after several manufacturers launched generic versions of Dapagliflozin tablets following the recent ruling by the UK Court of Appeal to invalidate AstraZeneca’s patent for the brand Forxiga.

From September 2025, reimbursement of generically written prescriptions for Dapagliflozin tablets will be based on the prices published in the September 2025 Drug Tariff.

• Dapagliflozin 5mg tablets (Price decrease from £36.59 to £25.89)

• Dapagliflozin 10mg tablets (Price decrease from £36.59 to £30.15)

All branded prescriptions will continue to be reimbursed in line with the NHS list prices of Forxiga referenced from the DM&D price file as normal.

If you have any questions, please do not hesitate to contact the us on 0131 467 7766 or email pharmacy.services@cps.scot.

---